Cargando…

Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma

Background: The diffuse large B-cell lymphoma (DLBCL) is a heterogeneous lymphoma with a dismal outcome, due to approximately 40% patients will be relapsed or refractory to the standard therapy of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP). Therefore, we need u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Wenqi, Wang, Jinhuan, Jiang, Yanan, Hu, Xin, Tian, Ye, Chen, Long, Sun, Huimeng, Li, Yuhang, Liu, Su, Lv, Yangyang, Guo, Jing, Xu, Hong, Xing, Donghui, Zhai, Yixin, Tian, Linyan, Li, Cheng, He, Xiang, Luo, Kaiping, Pan, Yuan, Zhao, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969582/ https://www.ncbi.nlm.nih.gov/pubmed/36860924 http://dx.doi.org/10.7150/jca.80926

Ejemplares similares

A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma
por: Xu, Hong, et al.
Publicado: (2022)

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review
por: Tian, Linyan, et al.
Publicado: (2023)

Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency
por: Wang, Jinhuan, et al.
Publicado: (2020)

Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency
por: Wang, Jinhuan, et al.
Publicado: (2020)

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
por: Huang, Wenting, et al.
Publicado: (2017)

Significance of stromal-1 and stromal-2 signatures and biologic prognostic model in diffuse large B-cell lymphoma
por: Abdou, Asmaa Gaber, et al.
Publicado: (2017)

Profiling of ribose methylations in ribosomal RNA from diffuse large B-cell lymphoma patients for evaluation of ribosomes as drug targets
por: Krogh, Nicolai, et al.
Publicado: (2020)

Comprehensive scientometrics and visualization study profiles lymphoma metabolism and identifies its significant research signatures
por: Guo, Song-Bin, et al.
Publicado: (2023)

Prognostic significance of bone marrow infiltration detected by PET-CT in newly diagnosed diffuse large B cell lymphoma
por: Liang, Jin-Hua, et al.
Publicado: (2016)

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B‐cell lymphoma
por: Tian, Tian, et al.
Publicado: (2020)

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
por: Zhang, Wenqi, et al.
Publicado: (2021)

Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma
por: Plaça, Jessica Rodrigues, et al.
Publicado: (2022)

Cladribine Induces ATF4 Mediated Apoptosis and Synergizes with SAHA in Diffuse Large B-Cell Lymphoma Cells
por: Xu, Linyan, et al.
Publicado: (2020)

Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
por: Feng, Pengcheng, et al.
Publicado: (2021)

Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma
por: Zhang, Ying, et al.
Publicado: (2020)

Immune targeted therapy for diffuse large B cell lymphoma
por: Zheng, Yaxin, et al.
Publicado: (2021)

Expression and Prognostic Significance of PD-L2 in Diffuse Large B-Cell Lymphoma
por: Gu, Qianhui, et al.
Publicado: (2021)

Expression and Significance of Cyclin-Dependent Protein Kinase 6 in Diffuse Large B-Cell Lymphoma
por: Li, Jing, et al.
Publicado: (2022)

Primary breast diffuse large B cell lymphoma
por: Guo, Mengni, et al.
Publicado: (2022)

Predictive Significance of a New Prognostic Score for Patients With Diffuse Large B-Cell Lymphoma in the Interim-Positron Emission Tomography Findings
por: Kong, Yu, et al.
Publicado: (2016)

Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell Lymphoma
por: Bellas, Carmen, et al.
Publicado: (2014)

Clinical Significance of ALK-1 Gene Abnormalities in Diffuse Large Cell Lymphoma
por: Korashy, L., et al.
Publicado: (2012)

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
por: Lu, Ting-Xun, et al.
Publicado: (2019)

Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis
por: Wang, Jin, et al.
Publicado: (2017)

Diagnostic Significance of Diffusion-Weighted MRI in Renal Cancer
por: Lei, Yu, et al.
Publicado: (2015)

Structural signatures of antibiotic binding sites on the ribosome
por: David-Eden, Hilda, et al.
Publicado: (2010)

Expression of Keap1 and Nrf2 in diffuse large B-cell lymphoma and its clinical significance
por: Yi, Xuemei, et al.
Publicado: (2018)

Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma
por: Zhang, Wei, et al.
Publicado: (2020)

Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma
por: Li, Zhongqi, et al.
Publicado: (2021)

Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma
por: Li, Yang, et al.
Publicado: (2022)

Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphoma
por: Wang, Huizhong, et al.
Publicado: (2021)

Differences in mutational signature of diffuse large B‐cell lymphomas according to the primary organ
por: Koh, Hyun‐Hee, et al.
Publicado: (2023)

Clinical Analysis and Prognostic Significance of Hepatitis B Virus Infections with Diffuse Large B-Cell Lymphoma
por: Kang, Xindan, et al.
Publicado: (2020)

A novel prognostic signature based on immune-related genes of diffuse large B-cell lymphoma
por: Wu, Zizheng, et al.
Publicado: (2021)

Comparison of PD‐L1 detection assays and corresponding significance in evaluation of diffuse large B‐cell lymphoma
por: Huang, Sixia, et al.
Publicado: (2019)

EHMT2 inhibitor BIX-01294 induces endoplasmic reticulum stress mediated apoptosis and autophagy in diffuse large B-cell lymphoma cells
por: Xu, Linyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nhas8mvd5ipn8npuajirn1gm0l